Posted in | News | Nanomedicine

ADA Technologies Receives Grant for Nanotechnology Imaging and Sensing Platforms

ADA Technologies, Inc. (ADA) received a $149,121 grant from the National Cancer Institute* for research and development of nanotechnology imaging and sensing platforms for improved detection and diagnosis of cancer.

ADA’s research focuses on developing a nano-enabled sensing platform for analysis of biomolecules, such as cancer biomarkers, that is more sensitive than existing technologies. Analysis platforms that provide high sensitivity and high throughput are critical to cancer biomarker detection.

“Our research will provide the scientific and medical communities with a reliable, ready-to-use platform that is capable of detecting multiple biomolecules to facilitate cancer biomarker screening and improve cancer diagnosis,” said Xichun Zhou, ADA principal investigator.

ADA’s R&D efforts related to nanotechnology imaging and sensing platforms began in 2007.

*This project is wholly funded with Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN261200800061C.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    ADA Technologies. (2019, March 19). ADA Technologies Receives Grant for Nanotechnology Imaging and Sensing Platforms. AZoNano. Retrieved on December 04, 2024 from https://www.azonano.com/news.aspx?newsID=9009.

  • MLA

    ADA Technologies. "ADA Technologies Receives Grant for Nanotechnology Imaging and Sensing Platforms". AZoNano. 04 December 2024. <https://www.azonano.com/news.aspx?newsID=9009>.

  • Chicago

    ADA Technologies. "ADA Technologies Receives Grant for Nanotechnology Imaging and Sensing Platforms". AZoNano. https://www.azonano.com/news.aspx?newsID=9009. (accessed December 04, 2024).

  • Harvard

    ADA Technologies. 2019. ADA Technologies Receives Grant for Nanotechnology Imaging and Sensing Platforms. AZoNano, viewed 04 December 2024, https://www.azonano.com/news.aspx?newsID=9009.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.